Oncotarget

Vol 11, No 35

September 1, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 35 of Oncotarget features Figure 4, "The in vivo pre- or post- topical application of BAY 11-7082 prevents the acidic bile-induced deregulation of cancer-related miRNA markers in 10-day exposed murine HM," by Vageli, et al.

Table of Contents

Editorial

Delivering a RAS protease halts tumor growth

Delivering a RAS protease halts tumor growth

https://doi.org/10.18632/oncotarget.27714

Vania Vidimar, Roman A. Melnyk,  and Karla J.F. Satchell
3265-3266
PDF  |  How to cite  |  Order a Reprint

Research Papers

Targeting 14-3-3ε-CDC25A interactions to trigger apoptotic cell death in skin cancer

Targeting 14-3-3ε-CDC25A interactions to trigger apoptotic cell death in skin cancer

https://doi.org/10.18632/oncotarget.27700

Thomas R. Holmes, Jenan Al-Matouq, Matti Holmes, Lauren Nicola, Justin C. Rudd, Sándor Lovas,  and Laura A. Hansen
3267-3278
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Sequencing for an interdisciplinary molecular tumor board in patients with advanced breast cancer: experiences from a case series

Sequencing for an interdisciplinary molecular tumor board in patients with advanced breast cancer: experiences from a case series

https://doi.org/10.18632/oncotarget.27704

Christina Walter, Andreas Hartkopf, Andre Koch, Marion Klaumünzer, Martin Schulze, Eva-Maria Grischke, Florin-Andrei Taran, Sara Brucker, Florian Battke,  and Saskia Biskup
3279-3285
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Ghrelin ameliorates tumor-induced adipose tissue atrophy and inflammation via Ghrelin receptor-dependent and -independent pathways

Ghrelin ameliorates tumor-induced adipose tissue atrophy and inflammation via Ghrelin receptor-dependent and -independent pathways

https://doi.org/10.18632/oncotarget.27705

Haiming Liu, Jiaohua Luo, Bobby Guillory, Ji-an Chen, Pu Zang, Jordan K. Yoeli, Yamileth Hernandez, Ian (In-gi) Lee, Barbara Anderson, Mackenzie Storie, Alison Tewnion,  and Jose M. Garcia
3286-3302
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

The temporal effects of topical NF-κB inhibition, in the in vivo prevention of bile-related oncogenic mRNA and miRNA phenotypes in murine hypopharyngeal mucosa: a preclinical model

The temporal effects of topical NF-κB inhibition, in the in vivo prevention of bile-related oncogenic mRNA and miRNA phenotypes in murine hypopharyngeal mucosa: a preclinical model

https://doi.org/10.18632/oncotarget.27706

Dimitra P. Vageli, David Kasle, Sotirios G. Doukas, Panagiotis G. Doukas,  and Clarence T. Sasaki
3303-3314
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin’s lymphoma to many other types of solid cancers

Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin’s lymphoma to many other types of solid cancers

https://doi.org/10.18632/oncotarget.27709

Rod Balhorn,  and Monique Cosman Balhorn
3315-3349
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Corrections

Correction: Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways

Correction: Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways

https://doi.org/10.18632/oncotarget.27369

Jianhong Yang, Heying Pei, Hong Luo, Afu Fu, Hansuo Yang, Jia Hu, Chengjian Zhao, LuLu Chai, Xiang Chen, Ximing Shao, Chunyu Wang, Wenshuang Wu, Li Wan, Haoyu Ye, Qiang Qiu, Aihua Peng, Yuquan Wei, Li Yang,  and Lijuan Chen
3350-3351
Correction  |  PDF  |  How to cite


Copyright © 2020 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC